Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100
- PMID: 12922132
- DOI: 10.1016/s0264-410x(03)00298-6
Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100
Abstract
Unfractionated GPI-0100 (UFGPI-0100) containing semi-synthetic derivatives of deacylated Quillaja saponins (DS saponins) modified at the glucuronic acid residue was resolved by reverse phase low-pressure liquid chromatography (RP-LPLC) into two fractions, RP18-1 and RP18-2, with different compositions and adjuvanticity. The fraction RP18-1 contained DS saponin adducts of N-dicyclohexylurea, and stimulated Th2 immunity with production of IgG1, while the RP18-2 fraction contained the dodecylamide derivatives of DS saponins and stimulated Th1 immunity with production of IgG2a, IFN-gamma, IL-2, and CTL. The strong immune stimulatory properties of RP18-2, relative to RP18-1, and the formation of RP18-1/RP18-2 mixed micelles may account for the effective stimulation of Th1 immunity by UFGPI-0100. UFGPI-0100 was free of acylated quillaja saponin components, including the more stable QS-7.
Similar articles
-
Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100.Vaccine. 2022 Jul 29;40(31):4169-4173. doi: 10.1016/j.vaccine.2022.05.084. Epub 2022 Jun 7. Vaccine. 2022. PMID: 35688726
-
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.Vaccine. 2000 Jul 15;18(27):3141-51. doi: 10.1016/s0264-410x(00)00118-3. Vaccine. 2000. PMID: 10856794
-
Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.Vaccine. 2018 Jan 2;36(1):55-65. doi: 10.1016/j.vaccine.2017.11.030. Epub 2017 Nov 23. Vaccine. 2018. PMID: 29174676
-
Advances in saponin-based adjuvants.Vaccine. 2009 Mar 13;27(12):1787-96. doi: 10.1016/j.vaccine.2009.01.091. Epub 2009 Feb 7. Vaccine. 2009. PMID: 19208455 Review.
-
Foamy matters: an update on Quillaja saponins and their use as immunoadjuvants.Future Med Chem. 2019 Jun;11(12):1485-1499. doi: 10.4155/fmc-2018-0438. Epub 2019 Jul 15. Future Med Chem. 2019. PMID: 31304830 Review.
Cited by
-
A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.PLoS One. 2012;7(11):e50460. doi: 10.1371/journal.pone.0050460. Epub 2012 Nov 28. PLoS One. 2012. PMID: 23209745 Free PMC article.
-
TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.J Immunol. 2011 May 15;186(10):5772-83. doi: 10.4049/jimmunol.1003192. Epub 2011 Apr 15. J Immunol. 2011. PMID: 21498664 Free PMC article.
-
Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation.Vaccines (Basel). 2017 Jul 27;5(3):19. doi: 10.3390/vaccines5030019. Vaccines (Basel). 2017. PMID: 28749414 Free PMC article.
-
Natural and Synthetic Saponins as Vaccine Adjuvants.Vaccines (Basel). 2021 Mar 5;9(3):222. doi: 10.3390/vaccines9030222. Vaccines (Basel). 2021. PMID: 33807582 Free PMC article. Review.
-
Vaccine Adjuvants Derivatized from Momordica Saponins I and II.J Med Chem. 2019 Nov 14;62(21):9976-9982. doi: 10.1021/acs.jmedchem.9b01511. Epub 2019 Oct 28. J Med Chem. 2019. PMID: 31657920 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources